Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer

Giada Zurlo, Xijuan Liu, Mamoru Takada, Cheng Fan, Jeremy M. Simon, Travis S. Ptacek, Javier Rodriguez, Alex von Kriegsheim, Juan Liu, Jason W. Locasale, Adam Robinson, Jing Zhang, Jessica M. Holler, Baek Kim, Marie Zikanova, Jorgen Bierau, Ling Xie, Xian Chen, Mingjie Li, Charles M. PerouQing Zhang*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number5177
Number of pages15
JournalNature Communications
Volume10
DOIs
Publication statusPublished - 15 Nov 2019

Keywords

  • PROLINE-HYDROXYLATION
  • MASS-SPECTROMETRY
  • MESSENGER-RNA
  • HIF-ALPHA
  • PURINE
  • MYC
  • IDENTIFICATION
  • TUMORIGENESIS
  • METABOLISM
  • MIR22HG

Cite this

Zurlo, G., Liu, X., Takada, M., Fan, C., Simon, J. M., Ptacek, T. S., Rodriguez, J., von Kriegsheim, A., Liu, J., Locasale, J. W., Robinson, A., Zhang, J., Holler, J. M., Kim, B., Zikanova, M., Bierau, J., Xie, L., Chen, X., Li, M., ... Zhang, Q. (2019). Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer. Nature Communications, 10, [5177]. https://doi.org/10.1038/s41467-019-13168-4